These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 26880410

  • 1. Promising Effects of a Novel EP2 and EP3 Receptor Dual Agonist, ONO-8055, on Neurogenic Underactive Bladder in a Rat Lumbar Canal Stenosis Model.
    Sekido N, Kida J, Mashimo H, Wakamatsu D, Okada H, Matsuya H.
    J Urol; 2016 Aug; 196(2):609-16. PubMed ID: 26880410
    [Abstract] [Full Text] [Related]

  • 2. Further characterization of a novel EP2 and EP3 receptor dual agonist, ONO-8055, on lower urinary tract function in normal and lumbar canal stenosis rats.
    Sekido N, Kida J, Otsuki T, Mashimo H, Matsuya H, Okada H.
    Low Urin Tract Symptoms; 2020 Jan; 12(1):99-106. PubMed ID: 31430051
    [Abstract] [Full Text] [Related]

  • 3. EP2 and EP3 receptors as therapeutic targets for underactive bladder/detrusor underactivity due to diabetic cystopathy in a type 1 diabetic rat model.
    Sekido N, Otsuki T, Kida J, Mashimo H, Wakamatsu D, Okada H, Matsuya H.
    Low Urin Tract Symptoms; 2020 Sep; 12(3):285-291. PubMed ID: 32410343
    [Abstract] [Full Text] [Related]

  • 4. Effects of an EP2 and EP3 Receptor Dual Agonist, ONO-8055, on a Radical Hysterectomy-Induced Underactive Bladder Model in Monkeys.
    Matsuya H, Sekido N, Kida J, Mashimo H, Wakamatsu D, Okada H.
    Low Urin Tract Symptoms; 2018 May; 10(2):204-211. PubMed ID: 28439968
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A novel animal model of underactive bladder: analysis of lower urinary tract function in a rat lumbar canal stenosis model.
    Sekido N, Jyoraku A, Okada H, Wakamatsu D, Matsuya H, Nishiyama H.
    Neurourol Urodyn; 2012 Sep; 31(7):1190-6. PubMed ID: 22473471
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. ASP6432, a type 1 lysophosphatidic acid receptor antagonist, reduces urethral function during urine voiding and improves voiding dysfunction.
    Sakamoto K, Noguchi Y, Imazumi K, Ueshima K, Ohtake A, Takeda M, Masuda N.
    Eur J Pharmacol; 2019 Mar 15; 847():83-90. PubMed ID: 30658116
    [Abstract] [Full Text] [Related]

  • 10. Discovery of highly potent dual EP(2) and EP(3) agonists with subtype selectivity.
    Kinoshita A, Higashino M, Aratani Y, Kakuuchi A, Matsuya H, Ohmoto K.
    Bioorg Med Chem Lett; 2016 Feb 01; 26(3):1016-1019. PubMed ID: 26725951
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differential regulation of airway smooth muscle cell migration by E-prostanoid receptor subtypes.
    Aso H, Ito S, Mori A, Suganuma N, Morioka M, Takahara N, Kondo M, Hasegawa Y.
    Am J Respir Cell Mol Biol; 2013 Mar 01; 48(3):322-9. PubMed ID: 23221043
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prostaglandin E2-induced modification of tetrodotoxin-resistant Na+ currents involves activation of both EP2 and EP4 receptors in neonatal rat nodose ganglion neurones.
    Matsumoto S, Ikeda M, Yoshida S, Tanimoto T, Takeda M, Nasu M.
    Br J Pharmacol; 2005 Jun 01; 145(4):503-13. PubMed ID: 15821755
    [Abstract] [Full Text] [Related]

  • 15. Antimuscarinic drug inhibits detrusor overactivity induced by topical application of prostaglandin E2 to the urethra with a decrease in urethral pressure.
    Yokoyama O, Miwa Y, Oyama N, Aoki Y, Ito H, Akino H.
    J Urol; 2007 Nov 01; 178(5):2208-12. PubMed ID: 17870108
    [Abstract] [Full Text] [Related]

  • 16. Improvement in bladder storage function by tamsulosin depends on suppression of C-fiber urethral afferent activity in rats.
    Yokoyama O, Yusup A, Oyama N, Aoki Y, Miwa Y, Akino H.
    J Urol; 2007 Feb 01; 177(2):771-5. PubMed ID: 17222679
    [Abstract] [Full Text] [Related]

  • 17. Effect of Selective Prostaglandin E2 EP2 Receptor Agonist CP-533,536 on Voiding Efficiency in Rats with Midodrine-Induced Functional Urethral Obstruction.
    Kurihara R, Imazumi K, Takamatsu H, Ishizu K, Yoshino T, Masuda N.
    Low Urin Tract Symptoms; 2016 May 01; 8(2):130-5. PubMed ID: 27111626
    [Abstract] [Full Text] [Related]

  • 18. Urethral dysfunction and therapeutic effects of a PDE 5 inhibitor (tadalafil) in a rat model of detrusor underactivity induced by pelvic nerve crush injury.
    Takaoka EI, Kurobe M, Suzuki T, Shimizu N, Kwon J, Okada H, Yoshimura N, Chermansky CJ.
    Neurourol Urodyn; 2020 Mar 01; 39(3):916-925. PubMed ID: 32040866
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. An EP2 Agonist Facilitates NMDA-Induced Outward Currents and Inhibits Dendritic Beading through Activation of BK Channels in Mouse Cortical Neurons.
    Hayashi Y, Morinaga S, Liu X, Zhang J, Wu Z, Yokoyama T, Nakanishi H.
    Mediators Inflamm; 2016 Mar 01; 2016():5079597. PubMed ID: 27298516
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.